Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium in Medullary Thyroid Cancer
NCT00582712Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Jan 2008
- Primary completion
- May 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lithium carbonate in Medullary Thyroid Cancer (MTC), sponsored by University of Wisconsin–Madison. Primary endpoint: Tumor Response Rate Measured by the Response Evaluation Criteria in Solid Tumors at 1 year. Started Jan 2008; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
Medullary Thyroid Cancer (MTC)
Beyond the preview
Go deeper on NCT00582712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582712.